Company: AZN
Filing Date: 2025-09-29
Form Type: 6-K
Source: 0001104659-25-094039
Chunk: 43

Company: ASTRAZENECA PLC
Filing Date: 2025-09-29
Form: 6-K
Chunk 43
---
 been given on a website in the form of an answer to a question; or (iii) it is undesirable in the interests of the Company or the good order of the meeting that the question be answered.

Registration of Shareholder questions

We encourage Shareholders to register any questions they may have for the Board in advance of the General Meeting so that all views are heard even if a Shareholder is unable to participate on the day. Shareholders can register questions in advance until 2:30 p.m. (GMT) on 30 October 2025 at https://www.astrazeneca.com/ investor-relations/shareholder-information.html#2025-0.

You are still welcome to ask a question at the General Meeting via the online platform irrespective of whether you have registered your question in advance. However, by registering your question in advance, you will help the Board to provide you with a more comprehensive answer. If you are unable to, or do not wish to, participate in the General Meeting on the day, you may also choose to receive a written response to your question or have it put to the Board during the General Meeting.

<div align='center'>34</div>

TABLE OF CONTENTS

Full details of how to ask a question via the online platform during the General Meeting are set out from page 39.

Please endeavour to keep your questions concise and relevant to the business of the General Meeting. Where we receive a number of questions covering the same topic, we may group these to address as many of your queries as possible. Additionally, we may remove supporting statements or paraphrase questions to ensure they are clear and concise.

Entitlement to participate and vote

Pursuant to Regulation 41 of the Uncertificated Securities Regulations 2001, only holders of AstraZeneca Shares entered in the Register of Members of the Company by 6:30 p.m. (GMT) on 30 October 2025 or, if the General Meeting is adjourned, at 6:30 p.m. (GMT) on the day which is two working days prior to any adjourned meeting, (or, in each case, their duly appointed proxies or Nominated Persons) are entitled to participate or vote at the General Meeting in respect of the number of AstraZeneca Shares registered in their name at that time. Changes to the entries in the Register of Members after 6:30 p.m. (GMT) on 30 October 2025, or if this meeting is adjourned, in the